BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15833881)

  • 1. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TGF-beta in cancer and the potential for therapy and prevention.
    Kaklamani VG; Pasche B
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):649-61. PubMed ID: 15270668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.
    Le Marchand L; Haiman CA; van den Berg D; Wilkens LR; Kolonel LN; Henderson BE
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):412-5. PubMed ID: 15006917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
    Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
    J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
    Chen T; Jackson CR; Link A; Markey MP; Colligan BM; Douglass LE; Pemberton JO; Deddens JA; Graff JR; Carter JH
    Clin Cancer Res; 2006 Jan; 12(2):392-7. PubMed ID: 16428477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
    Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
    Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
    McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
    BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
    Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
    Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk.
    Lee KM; Park SK; Hamajima N; Tajima K; Yoo KY; Shin A; Noh DY; Ahn SH; Hirvonen A; Kang D
    Breast Cancer Res Treat; 2005 Mar; 90(2):149-55. PubMed ID: 15803361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
    Colleran G; McInerney N; Rowan A; Barclay E; Jones AM; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
    Breast Cancer Res Treat; 2010 Jan; 119(2):437-42. PubMed ID: 19390964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the transforming growth factor-beta signaling pathways and breast cancer risk and survival.
    Zheng W
    Methods Mol Biol; 2009; 472():265-77. PubMed ID: 19107437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TbetaR-I(6A) is a candidate tumor susceptibility allele.
    Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
    Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages.
    Shin A; Shu XO; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1567-70. PubMed ID: 15941974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta receptor type I and transforming growth factor beta1 polymorphisms are not associated with postmenopausal breast cancer.
    Feigelson HS; Patel AV; Diver WR; Stevens VL; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1236-7. PubMed ID: 16775189
    [No Abstract]   [Full Text] [Related]  

  • 18. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
    Gu D; Zhuang L; Huang H; Cao P; Wang D; Tang J; Chen J
    Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women.
    Zheng SL; Zheng W; Chang BL; Shu XO; Cai Q; Yu H; Dai Q; Xu J; Gao YT
    Cancer Res; 2003 Nov; 63(22):7624-9. PubMed ID: 14633679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies.
    Zhang HT
    Lung Cancer; 2005 Sep; 49(3):419-20. PubMed ID: 15955593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.